Evaluation of an Interim Crohn's Disease Outcome Measure (PRO-2) Based on 2 Patient-Reported Components (Stool Frequency, Abdominal Pain) of the Crohn's Disease Activity Index (CDAI) in the Ustekinumab CERTIFI Study

Gasink Christopher; Friedman Joshua; Gao Long Long; Chan Daphne; Sandborn William; Feagan Brian

首页> 外文期刊>The American Journal of Gastroenterology >Evaluation of an Interim Crohn's Disease Outcome Measure (PRO-2) Based on 2 Patient-Reported Components (Stool Frequency, Abdominal Pain) of the Crohn's Disease Activity Index (CDAI) in the Ustekinumab CERTIFI Study

【24h】

Evaluation of an Interim Crohn's Disease Outcome Measure (PRO-2) Based on 2 Patient-Reported Components (Stool Frequency, Abdominal Pain) of the Crohn's Disease Activity Index (CDAI) in the Ustekinumab CERTIFI Study

机译：在Ustekinumab CERTIFI研究中基于2个患者报告的克罗恩病活动指数（CDAI）的患者报告成分（粪便频率，腹部疼痛）评估临时克罗恩病结果指标（PRO-2）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The American Journal of Gastroenterology》 |2014年第2期|共1页
作者
Gasink Christopher; Friedman Joshua; Gao Long Long; Chan Daphne; Sandborn William; Feagan Brian;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献

1. Evaluation of an Interim Crohn's Disease Outcome Measure (PRO-2) Based on 2 Patient-Reported Components (Stool Frequency, Abdominal Pain) of the Crohn's Disease Activity Index (CDAI) in the Ustekinumab CERTIFI Study [J] . Gasink Christopher, Friedman Joshua, Gao Long Long, The American Journal of Gastroenterology . 2014,第Suppla2期

机译：在Ustekinumab CERTIFI研究中基于2个患者报告的克罗恩病活动指数（CDAI）的患者报告成分（粪便频率，腹部疼痛）评估临时克罗恩病结果指标（PRO-2）
2. Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease [J] . Lewis James D., Rutgeerts Paul, Feagan Brian G., Inflammatory bowel diseases . 2020,第2期

机译：大便频率与腹痛措施与简单的内窥镜评分对克罗恩病的相关性
3. Challenges in longitudinal exposure-response modeling of data from complex study designs: a case study of modeling CDAI score for ustekinumab in patients with Crohn's disease [J] . Hu Chuanpu, Adedokun Omoniyi J., Chen Yang, Journal of pharmacokinetics and pharmacodynamics . 2017,第5期

机译：复杂研究设计中数据纵向曝光响应建模的挑战 - 以克罗恩病患者Ustekinumab建模CDAI分数的案例研究
4. A Supervised Learning Based Approach to Detect Crohn's Disease in Abdominal MR Volumes [C] . Dwarikanath Mahapatra, Peter Schueffler, Jeroen A.W. Tielbeek, Abdominal imaging: computational and clinical applications. . 2012

机译：基于监督学习的腹部MR量克罗恩病检测方法
5. Correlation of Patient-Reported Outcome (PRO-2) with Endoscopic and Histological Features in Ulcerative Colitis and Crohns Disease Patients [O] . Sanja Dragasevic, Aleksandra Sokic-Milutinovic, Milica Stojkovic Lalosevic, 2020

机译：溃疡性结肠炎和克罗恩病患者的患者报告结果（PRO-2）与内镜和组织学特征的相关性
6. The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome [O] . C. Lahiff, P. Safaie, A. Awais, 2013

机译：克罗恩病的患者和肠症综合征患者患者同样升高了CROHN的疾病活动指数（CDAI）

Evaluation of an Interim Crohn's Disease Outcome Measure (PRO-2) Based on 2 Patient-Reported Components (Stool Frequency, Abdominal Pain) of the Crohn's Disease Activity Index (CDAI) in the Ustekinumab CERTIFI Study

著录项

相似文献

相关主题

期刊订阅